Pallorin, Jovelyn .
HRN: 23-36-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/20/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/20/2023
07/27/2023
IV
4.5
Q6
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes